title: Drugs to avoid during pregnancy: omalizumab and montelukast, too many uncertainties.
mesh_terms: D000085:Acetates / Q000009:adverse effects*; D018927:Anti-Asthmatic Agents / Q000009:adverse effects*; D000888:Antibodies, Anti-Idiotypic / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D001249:Asthma / Q000188:drug therapy*; D003521:Cyclopropanes; D005260:Female; D006801:Humans; D000069444:Omalizumab; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011804:Quinolines / Q000009:adverse effects*; D013440:Sulfides
chemical_list: D000085:Acetates; D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D003521:Cyclopropanes; D011804:Quinolines; D013440:Sulfides; D000069444:Omalizumab; C093875:montelukast